Soltész P - Search Results

1

Combined plasmapheresis and high-dose intravenous immunoglobulin treatment in systemic sclerosis for 12 months: follow-up of immunopathological and clinical effects.

Szekanecz Z, Aleksza M, Antal-Szalmás P, Soltész P, Veres K, Szántó S, Szabó Z, Végvári A, Szamosi S, Lakos G, Sipka S, Szegedi G, Varga J, Szücs G. Szekanecz Z, et al. Among authors: soltesz p. Clin Rheumatol. 2009 Mar;28(3):347-50. doi: 10.1007/s10067-008-1062-2. Epub 2008 Dec 6. Clin Rheumatol. 2009. PMID: 19067103

2

Association of HELLP syndrome with primary antiphospholipid syndrome--a case report.

Veres K, Papp K, Lakos G, Szomják E, Szekanecz Z, Szegedi G, Soltész P. Veres K, et al. Among authors: soltesz p. Clin Rheumatol. 2008 Jan;27(1):111-3. doi: 10.1007/s10067-007-0687-x. Epub 2007 Aug 8. Clin Rheumatol. 2008. PMID: 17684701

3

Increased arterial stiffness as the marker of vascular involvement in systemic sclerosis.

Timár O, Soltész P, Szamosi S, Dér H, Szántó S, Szekanecz Z, Szücs G. Timár O, et al. Among authors: soltesz p. J Rheumatol. 2008 Jul;35(7):1329-33. Epub 2008 May 15. J Rheumatol. 2008. PMID: 18484693

4

A comparative study of arterial stiffness, flow-mediated vasodilation of the brachial artery, and the thickness of the carotid artery intima-media in patients with systemic autoimmune diseases.

Soltész P, Dér H, Kerekes G, Szodoray P, Szücs G, Dankó K, Shoenfeld Y, Szegedi G, Szekanecz Z. Soltész P, et al. Clin Rheumatol. 2009 Jun;28(6):655-62. doi: 10.1007/s10067-009-1118-y. Epub 2009 Feb 18. Clin Rheumatol. 2009. PMID: 19224126

5

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis.

Kerekes G, Soltész P, Dér H, Veres K, Szabó Z, Végvári A, Szegedi G, Shoenfeld Y, Szekanecz Z. Kerekes G, et al. Among authors: soltesz p. Clin Rheumatol. 2009 Jun;28(6):705-10. doi: 10.1007/s10067-009-1095-1. Epub 2009 Mar 25. Clin Rheumatol. 2009. PMID: 19319624 Clinical Trial.

6

Endothelial dysfunction precedes atherosclerosis in systemic sclerosis--relevance for prevention of vascular complications.

Szucs G, Tímár O, Szekanecz Z, Dér H, Kerekes G, Szamosi S, Shoenfeld Y, Szegedi G, Soltész P. Szucs G, et al. Among authors: soltesz p. Rheumatology (Oxford). 2007 May;46(5):759-62. doi: 10.1093/rheumatology/kel426. Epub 2007 Jan 23. Rheumatology (Oxford). 2007. PMID: 17244666

7

Plasmapheresis modulates Th1/Th2 imbalance in patients with systemic lupus erythematosus according to measurement of intracytoplasmic cytokines.

Soltész P, Aleksza M, Antal-Szalmás P, Lakos G, Szegedi G, Kiss E. Soltész P, et al. Autoimmunity. 2002 Feb;35(1):51-6. doi: 10.1080/08916930290005909. Autoimmunity. 2002. PMID: 11908707 Free article.

8

Serum cytokine levels and type 1 and type 2 intracellular T cell cytokine profiles in mixed connective tissue disease.

Bodolay E, Aleksza M, Antal-Szalmás P, Végh J, Szodoray P, Soltész P, Szegedi A, Szekanecz Z. Bodolay E, et al. Among authors: soltesz p. J Rheumatol. 2002 Oct;29(10):2136-42. J Rheumatol. 2002. PMID: 12375323

9

[Plasmapheresis therapy in systemic sclerosis].

Szúcs G, Szamosi S, Aleksza M, Veres K, Soltész P. Szúcs G, et al. Among authors: soltesz p. Orv Hetil. 2003 Nov 9;144(45):2213-7. Orv Hetil. 2003. PMID: 14686006 Hungarian.

10

Clinical thrombotic manifestations in SLE patients with and without antiphospholipid antibodies: a 5-year follow-up.

Tarr T, Lakos G, Bhattoa HP, Soltesz P, Shoenfeld Y, Szegedi G, Kiss E. Tarr T, et al. Among authors: soltesz p. Clin Rev Allergy Immunol. 2007 Apr;32(2):131-7. doi: 10.1007/s12016-007-0009-8. Clin Rev Allergy Immunol. 2007. PMID: 17916982

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters